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Abstract 
Background: Care coordination is considered important for patients with rare conditions, yet research addressing 
the impact of care coordination is limited. This study aimed to explore how care coordination (or lack of ) impacts 
on patients and carers. Semi‑structured interviews were conducted with 15 patients and carers/parents in the UK, 
representing a range of rare conditions (including undiagnosed conditions). Transcripts were analysed thematically in 
an iterative process.
Results: Participants described a range of experiences and views in relation to care coordination. Reports of uncoor‑
dinated care emerged: appointments were uncoordinated, communication between key stakeholders was ineffective, 
patients and carers were required to coordinate their own care, and care was not coordinated to meet the changing 
needs of patients in different scenarios. As a result, participants experienced an additional burden and barriers/delays 
to accessing care. The impacts described by patients and carers, either attributed to or exacerbated by uncoordinated 
care, included: impact on physical health (including fatigue), financial impact (including loss of earnings and travel 
costs), and psychosocial impact (including disruption to school, work and emotional burden). Overall data highlight 
the importance of flexible care, which meets individual needs throughout patients’/carers’ journeys. Specifically, study 
participants suggested that the impacts may be addressed by: having support from a professional to coordinate care, 
changing the approach of clinics and appointments (where they take place, which professionals/services are available 
and how they are scheduled), and improving communication through the use of technology, care plans, accessible 
points of contact and multi‑disciplinary team working.
Conclusion: This study provides further evidence of impacts of uncoordinated care; these may be complex and 
influenced by a number of factors. Approaches to coordination which improve access to care and lessen the time 
and burden placed on patients and carers may be particularly beneficial. Findings should influence future service 
developments (and the evaluation of such developments). This will be achieved, in the first instance, by informing the 
CONCORD Study in the UK.
Keywords: Care coordination, Financial impact, Psychosocial impact, Undiagnosed conditions, Patient experience, 
Carer experience, Care coordinators, Multi‑disciplinary clinics, Specialist care, Care plans
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Background
Following a recent review of definitions [1], care coor-
dination for chronic and rare conditions has been 
defined as follows: [p. 8]
Coordination of care involves working together 
across multiple components and processes of 
care to enable everyone involved in a patient’s 
care (including a team of healthcare profession-
als, the patient and/or carer and their family) to 
avoid duplication and achieve shared outcomes, 
throughout a person’s whole life, across all parts 
of the health and care system. Coordination of 
care should be family-centred, holistic (includ-
ing a patient’s medical, psychosocial, educational 
and vocational needs), evidence-based, with equal 
access to coordinated care irrespective of diagno-
sis, patient circumstances and geographical loca-
tion.
In the United Kingdom (UK), coordinated care for 
patients with rare conditions is provided in different ways 
such as through specialist centres, care coordinators, 
multi-disciplinary teams, care plans and ‘one-stop-shops’/
residential clinics where patients can access a range of 
services during one hospital visit [2]. However, services 
are not delivered in the same way across the country and 
experiences can depend on the condition, patients’ age, 
and their location [2–4] and many rare disease patients 
are not aware of or do not access a specialist centre [4].
Improving the coordination of care for rare condi-
tions is a priority for UK government strategy [5] and 
NHS (National Health Service) England state in their 
implementation plan [6] that specialised services should 
include: a person responsible for coordination, an alert 
card and an active transition from paediatric to adult 
services. However, progress is limited [2, 7] and more 
research is needed in the UK, and across Europe, to dem-
onstrate the effectiveness of specific elements of rare dis-
ease plans on patient outcomes [8].
Research has indicated that coordinating care for rare 
conditions may be more complex than it is for common 
chronic conditions, for example, coordination may be 
required in the context of no diagnosis and/or a lack of 
awareness and expertise in the condition [1]. An individ-
ual’s health needs are often shared over clinical subspe-
cialties [9] and they are also likely to require coordination 
across a range of other support needs and professionals 
(including social care and education) [1].
Limited research suggests that there may be both finan-
cial and non-financial ‘hidden’ impacts for patients and 
their families, associated with how care is coordinated [2, 
3]. A range of challenges related to how care is managed 
have been identified including:
(a) psychological and emotional challenges result-
ing from high turnover of healthcare professionals 
and a lack of information and knowledge amongst 
professionals [10],
(b) stress and financial concerns for parents due to 
the burden associated with planning and coordi-
nating care to meet the unique needs of their chil-
dren [11] and,
(c) a substantial time burden for patients and car-
ers, in part, because of coordinating their care [12].
Specialised treatment centres/teams have been per-
ceived to have positive outcomes, including being 
characterised with more experience and knowledge, 
yielding better patient satisfaction [10] and specialist 
multi-disciplinary ‘one stop shops’ have demonstrated 
more organised, personalised and holistic care, result-
ing in better treatment compliance [9]. However, a 
number of challenges in assessing models of care coor-
dination for rare diseases have been identified by econ-
omists including small numbers of patients, making it 
challenging to know how to organise care appropriately 
[13].
So, while care coordination is considered impor-
tant for patients with rare conditions, there is a lack 
of research which addresses care coordination in the 
context of rare conditions [1]. More specifically, there 
is a dearth of evidence on the impact of different 
approaches to care coordination for such patient groups 
[14] including the impact on patients and their families 
[2, 3]. It has also been noted that where research does 
exist, it tends to be condition specific, and there is a 
lack of qualitative research which addresses the shared 
experience of those with rare conditions [10].
Given this paucity of data in this area, the aim of this 
study was to (i) explore how rare disease patients and 
their carers are impacted by how their care is, or is not, 
coordinated, and (ii) explore the factors which might 
influence effective care coordination from the  perspec-
tive  of patients and carers. Qualitative methodology 
is ideally suited for investigating psychological, emo-
tional and social impacts of living with a rare condition 
[10]. Using qualitative research (with patients and carers 
affected by a range of conditions) to understand what the 
impacts of care coordination might be, is an important 
initial step in the future evaluation and design of different 
models of care for patients with rare conditions.
Methods
Ethical approval
The research was approved by University College Lon-
don’s research ethics committee (project ID 8423/002).
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Design
This was an exploratory qualitative interview study of 
patients affected by rare conditions (including undiag-
nosed conditions) and their carers. Data was analysed 
thematically [15], in an iterative process, using both 
inductive and deductive approaches.
Recruitment
We recruited patients and carers (including parents of 
patients and spouses/partners of adult patients) affected 
by rare conditions in the UK. Participants were recruited 
from charity networks (Genetic Alliance UK, Rare Dis-
ease UK and Syndromes Without A Name (SWAN) UK) 
using a purposive sampling method. An advert, invit-
ing interested individuals to contact the research team, 
was disseminated via email (newsletters and members’ 
updates), social media, and charity websites.
Purposive sampling methods are widely used in qualita-
tive research so that the most ‘information-rich’ cases can 
be identified and selected [16]. The purpose of our analy-
sis was to get a rich understanding of the experience of a 
number of patients and carers—not to be representative 
of all people with an experience of rare diseases. How-
ever, the approach was adopted to gather data on impacts 
from several different perspectives including from those 
experiencing different approaches to coordination. In 
October 2018, participants were selected from 60 indi-
viduals. A sample was specifically chosen to include: 
patients and carers, those with and without a diagno-
sis, and those with a range of coordination experiences 
(including those who had a professional coordinating 
their care and those who coordinated care themselves, 
those who attended a specialist centre and those who did 
not). Participants were also selected to represent a range 
of ages and locations across the UK. Further details of 
participants’ characteristics are included in the results 
section.
Data collection
Interviews were semi-structured and conducted by tel-
ephone or Skype. All participants received a participant 
information sheet and consent form via email, and were 
given the opportunity to discuss the study and ask the 
researcher questions, before they agreed to take part. 
Interviews were scheduled at a time convenient for the 
participant. Verbal informed consent was taken and 
recorded at the start of the interviews. Fifteen interviews 
were conducted (by AS) between October 2018 and Janu-
ary 2019 (telephone: n = 14, Skype: n = 1). Interviews 
ranged from 34 to 93 min (mean: 51 min).
The interview questions were informed by findings of 
a feasibility study exploring the hidden costs of rare dis-
eases [2] and included questions about how care was 
currently organised and how individuals would like it to 
be organised, what was important to them in relation to 
care coordination (and how this might change over time) 
and the costs and benefits associated with how care is 
coordinated (see Additional file 1).
Interviews were recorded using an encrypted Dicta-
phone and transcribed verbatim by a professional tran-
scribing company. Transcripts were read and checked for 
accuracy (by AS). Personal information (such as names 
and places) were removed prior to analysis.
Analysis
The primary researcher (AS) read transcripts and made 
initial notes. Codes were identified from a previous fea-
sibility study (e.g. different types of costs and benefits 
such as ‘financial’ and ‘psychosocial’) [2]. In addition, two 
members of the research team (AS and EH) each open-
coded two transcripts to identify new codes. A draft 
coding framework, including both anticipated and emer-
gent codes, was developed. Three transcripts were then 
independently coded by two researchers (AS and HW), 
who met to share their coding. Any disagreements were 
discussed until a consensus was met. The revised cod-
ing frame was then applied to all remaining transcripts 
by the primary researcher (AS) using QSR NVivo 12 [17] 
qualitative data analysis programme. To develop themes, 
a process of Iterative Categorisation (IC) [18] was fol-
lowed to systematically reduce, review and summarise 
the data. Ideas were shared with the study team (several 
members of which were experts from the clinical and vol-
untary sector).
Results
Participant characteristics were collected prior to inter-
view. Participants included both patients affected by rare 
diseases (7) and carers (8).1 Carers were all informal car-
ers (they were not carers by profession—they were either 
the parent of a child with a rare disease or the spouse/






Diagnosed 5 4 2 11
Undiagnosed 2 2 0 4
Total 7 6 2 15
1 One participant had a child who had been diagnosed with the same condi-
tion as them – the participant is recorded as a patient (rather than parent) in 
the Table 1, although they were able to talk from both perspectives.
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partner of an adult with a rare disease). Participants were 
a range of ages: one participant was aged between 18 and 
25,  12 participants were aged between 26 and 59,  and 
two were aged 60 or over. Patient age (age of patients 
cared for) also ranged: six were under 18 and two were 
aged between  26  and  59. Participants lived in different 
regions across the UK including East Midlands (3), East 
of England (2), Greater London (2), North East (1), North 
West (1), South East (3), South West (2) and Scotland (1). 
Further characteristics, including whether the patient 
had a diagnosis, who coordinates care and whether par-
ticipants had access to a specialist centre,2 are shown in 
Tables 1 and 2.
Findings to address the aims are grouped under three 
main headings: Experiences of uncoordinated care for 
patients with rare conditions, How uncoordinated care 
impacts on patients and carers, and Examples of coordi-
nated care and approaches to reduce the negative impacts 
of imperfect care coordination on patients and carers.
Experiences of uncoordinated care for patients with rare 
conditions
Participants described a range of experiences of uncoor-
dinated care (see Fig. 1 ‘A. Experiences of uncoordinated 
care’). These included:
• Uncoordinated appointments: frequent appoint-
ments to see different professionals/services across 
different NHS settings, some of which were located 
far away from home (i.e. at specialist centres), lack of 
choice about when or where their appointments took 
place, and appointments with one professional at a 
time (with little evidence of medical and non-medical 
services being offered in the same clinic).
• Ineffective communication between stakeholders: 
lack of communication/team approach across vari-
ous care professionals (particularly between those in 
specialist centres and local teams), no point of con-
tact to approach with queries, problems relating to 
information sharing (particularly the timeliness of 
information sharing), and limited use of care plans.
• Patients and carers coordinating their own care: 
patients and carers undertaking a number of tasks 
including chasing services, holding information and 
facilitating information sharing.   Many reported 
being the main coordinator of care.
In addition, the data showed that care is not coordi-
nated to meet the needs of different patients and sce-
narios. Care was uncoordinated at particular stages of 
the patient journey—in particular, there were challenges 
associated with: emergencies or acute episodes (with a 
lack of awareness locally and difficulties accessing timely 
treatment), pre and post diagnosis (particularly in estab-
lishing care and support), following discharge from 
hospital (and receiving the appropriate care within the 
community), and transitioning from paediatric to adult 
services. Similarly, care was considered uncoordinated 
if it did not meet individual patient needs (for example, 
appointments were not scheduled to allow for minimum 
disruption to work/school). Experiences of uncoordi-
nated care therefore varied across individuals and stages 
of the patient journey.
How uncoordinated care impacts on patients and carers
Uncoordinated care resulted in both delays/barriers to 
accessing care and a burden on patients and carers (see 
Fig. 1 ‘B. Outputs of uncoordinated care’), which in turn 
had several negative impacts for patients and carers (see 
Fig. 1 ‘C. Impacts on patients and carers’).
How did uncoordinated care influence patients’ access 
to care?
Interviewees reported that uncoordinated appointments 
and ineffective communication between stakeholders 
impacted on their ability to access care and access that 
care in a timely way. ‘Care’ included care that is special-
ist (care from professionals/settings which specialise in 
the condition and have specialist knowledge), care in dif-
ferent settings (including in local settings), non-medical 
care and support, proactive care, accurate diagnosis and 
treatment/medications.
Table 2 Access to a specialist centre/who coordinates care
















 Yes 3 0 4 7
 No 4 2 0 6
 Don’t 
know
2 0 0 2
Total 9 2 4 15
2 It is important to note that participants are likely to have interpreted ‘spe-
cialist centre’ differently as no definition was provided. Further detail was cap-
tured during the interviews and is described in the results section.
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Seeing numerous professionals over several different 
appointments resulted in delays in decision making about 
their care. Delays were also evident as a result of ineffec-
tive communication between professionals and informa-
tion sharing across different trusts/services—interviewees 
reported wasting time during appointments updating pro-
fessionals and/or waiting for them to chase results.
Initiatives which facilitated communication between 
professionals (e.g. care plans or multi-disciplinary meet-
ings) were limited. Therefore, even for those patients who 
accessed specialist care (i.e. via a specialist centre), the 
location and accessibility of specialist care/advice com-
bined with the lack of effective communication between 
local and specialist teams resulted in challenges, particu-
larly in accessing local care during acute scenarios.
I would imagine a lot of people with rare diseases 
find this: that when they turn up at their local hos-
pital whoever is on-shift generally has no idea what 
you’re talking about so you always have to go back to 
your Consultant [and] there could be delays [carer, 
diagnosed]
More than one interviewee reported facing delays in 
accessing their medication, again, as a result of ineffec-
tive communication between specialists and local ser-
vices. Patients and carers reported that health and other 
sectors, such as social care, did not communicate with 
each other, sometimes preventing vital access to non-
medical support.
it’s terrible the coordination between the Social 
Work side of things and the Health side of things. It 
took us 18  months actually to get a Social Worker, 
which seems crazy given that my son has a really 
profound disability. [carer, diagnosed]
How did the challenges associated with access to care impact 
negatively on patients and carers?
Such barriers and delays are likely to have consequences 
for patients and carers. First, it can have a negative 
impact on a patient’s physical health, particularly if diag-
nosis or treatment is delayed. Second, it can have a finan-
cial impact on families—participants reported paying for 
private health care as a last resort and as a result of delays 
or fighting for access to care. Third, it can have psycho-
social impacts –patients and carers reported on the emo-
tional impact of having to fight for their care and they 
experienced a loss of confidence in the care they received.
our main problem was obviously getting access to a 
doctor… who could do the appropriate tests… when 
[respondent’s son1] developed that squint… which 
was kind of about a year before, he should have been 
Figure 1 Patients’ and Carers’ experiences of uncoordinated care and their impact
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referred to a neurologist at that point. [carer, diag-
nosed]
It is important to note that impact on physical health is 
also likely to have further ‘knock on’ impacts for patients 
and carers. For example, poorer physical health could 
result in the need for more medical intervention (which, 
if uncoordinated could magnify many of the issues 
already faced) and increased challenges associated with 
daily activities such as going to work (carrying further 
financial and psychosocial costs).
How did uncoordinated care create additional burden 
on patients and carers?
Patients and carers described the time and burden 
placed upon them to attend frequent and uncoordinated 
appointments (patients and carers spent significant time 
travelling to and attending various appointments) and 
coordinate their own care (supporting communication/
information exchange and organising the vast appoint-
ment schedule).
In the absence of care coordination (and tools such as 
coordinators or care plans) families described having to 
adopt a proactive approach themselves to ensure they 
received the right care. This involved spending significant 
amounts of time chasing services for results, appoint-
ments and advice. One parent described their care coor-
dinating role as a full-time job, with no pay.
I’m the one that chases appointments and makes 
sure that we’re where we’re supposed to be … a 
huge amount of work but how can that really be 
improved? [carer, diagnosed]
Managing information relating to the patient’s condi-
tion and their care was a major task for families. Reports 
suggested that the records kept by professionals were 
sometimes incomplete or inaccurate. As a result, patients 
and carers were often required to update or correct pro-
fessionals at each appointment. Some kept detailed paper 
records at home, rather than relying on the records kept 
by professionals.
…If I ever got hit by a bus, we’d be screwed. Well, I 
wouldn’t be obviously, I’d be completely blissfully 
unaware, but he would be stuffed because all of this 
stuff is in my head. [carer, undiagnosed]
The time and burden associated with attending 
appointments and managing a care schedule is likely to 
affect all patients to some extent (including those with 
positive experiences of coordinated care). However, 
interviewees suggested that the costs were increased by 
(a) the uncoordinated nature of appointments—they 
were required to travel far and frequently for services 
which could, in theory, be offered locally and/or in one 
visit rather than several and (b) a lack of effective com-
munication between the various professionals involved 
across specialities and locations.
How did the additional burden impact negatively on patients 
and carers?
Participants reported that appointment schedules can 
have a negative impact on a patient’s physical health. This 
was a particular issue for those whose condition caused 
fatigue. In addition, participants reported financial costs 
associated with attending appointments, such as those 
for travel and parking, accommodation (if the distance 
was too great to complete a return journey on the same 
day), food and fees relating to childcare (e.g. for patients’ 
siblings whilst parents were attending appointments) 
and carers (e.g. professional carers required to support 
parents when travelling and attending appointments). 
Psychosocial costs of attending appointments were also 
reported—for example, young patients missed time at 
school as a result of attending appointments.
Obviously, it’s got a financial cost, but there’s a 
physical cost there, you know, having to go to extra 
appointments when I needn’t have to. [patient, diag-
nosed]
Patients and carers frequently referred to the impact of 
attending uncoordinated appointments and coordinat-
ing their care on work and employment. In part, this was 
a further financial cost to families (i.e. a loss of earnings 
from reducing their hours, changing the nature of their 
role at work, or leaving paid employment to cope with 
the demands). Disruption to work also carried a psycho-
social cost. Participants talked of strained relationships 
with colleagues and managers whilst negotiating time 
off and reducing hours, not having a break because they 
were using annual leave exclusively for appointments, 
and a loss of identity and self-esteem as a result of giving 
up their job and ‘independence’. This again demonstrates 
the multidirectional nature of some of the impacts—
there may be several ‘knock on’ impacts for patients and 
carers. In this instance, the financial impact of losing 
earnings had a psychosocial impact on participants.
…it has sort of an impact on your self-esteem, 
doesn’t it, because prior to having children I was a 
high-flyer and I was very independent and I earned 
a lot of money… whereas all of that has gone now; 
we’re living off the savings that my husband earned, 
I’m totally dependent on that and totally dependent 
on him. [carer, diagnosed]
The emotional impact of managing a rare condition, in 
particular taking on the role of care coordinator, was also 
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discussed by patients and carers. Words used to describe 
how the workload and burden made them feel included: 
exhausted, strained, frustrated, worried, suicidal, and ter-
rified. Parents, in particular, discussed feeling anxious 
about being the ‘expert’ and being responsible for look-
ing out for symptom changes and receiving little support. 
Isolation was also a common theme amongst parents, 
which was exacerbated by their workload (e.g. they did 
not have the time to socialise).
The way that it’s been coordinated has probably 
added to the stress… having to be that person that 
is chasing everything, that’s definitely added to the 
stress. [carer, diagnosed]
it’s absolutely relentless and exhausting and heart-
breaking. I’m on my seventh ring binder upstairs 
with all of the letters from the diagnoses and the 
medicine sheets…I’m just worried if I forget some-
thing. [carer, undiagnosed]
There were also additional administration costs for 
families of printing and posting paperwork (e.g. the costs 
of record keeping and sharing paperwork with relevant 
individuals and bodies).
Participants reported having to rely on others within 
their family for things such as support coordinating 
care and providing childcare for children whilst attend-
ing appointments. Therefore, the non-financial and 
psychosocial impacts were also felt by wider family mem-
bers who may have to support families practically and 
emotionally.
Examples of coordinated care and approaches to reduce 
the negative impacts of imperfect care coordination 
on patients and carers
The findings above suggest that how care is coordinated 
can have several consequences for patients and carers. 
Improving or changing the way in which care is coordi-
nated could improve access to care and reduce the time/
burden experienced by patients and carers. In turn, this 
would reduce the negative (physical, financial and psy-
chosocial) impacts described above. The data below 
(summarised in Table 3) emerged from examples of good 
coordination (currently experienced by participants) 
and/or participants’ suggestions for how coordination 
could be improved.
Having the support of a professional coordinator
One participant reported having a dedicated care 
coordinator within their specialist centre—they were 
a specialist nurse who acted as a point of contact for 
the patient, managed appointment scheduling and 
facilitated information sharing between relevant pro-
fessionals. The benefits reported by the participant 
included having a bank of expert knowledge that they 
could always refer to and reducing the burden on their 
parent.
Participants suggested a professional coordinator 
could support patients and carers in a range of other 
ways including: coordinating care across different pro-
viders (including local ones), facilitating proactive care, 
and helping families access wider support services 
(such as funding opportunities (e.g. for specialist equip-
ment within homes), social care and/or signposting to 
local charities who were seen as an important source 
of knowledge and support). Such support is likely to 
both improve access to care (especially locally, and both 
medical and non-medical) and reduce the time/burden 
on patients and carers associated with coordinating and 
fighting to access care.
Although it was agreed that having the support of a 
professional coordinator would be beneficial, there were 
diverse views about which professionals should ful-
fil the role of care coordinator, what type of training or 
background would be required, and when the support 
should be available. Therefore, different approaches may 
be required in different circumstances and/or with dif-
ferent patients. For example, some argued that a profes-
sional coordinator should be someone with a medical 
background or even someone who specialises in the con-
dition. Whereas some others argued it should be some-
one with good organisation skills (not necessarily with a 
medical background). Some interviewees felt that care 
coordinators should only take on specific coordinating 
tasks as required, rather than having continuous, regular 
involvement. The support of a care coordinator may have 
greater benefits at key points in the patient journey—for 
example, post diagnosis, after  hospital discharge and 
other transition periods (when care needs are being 
identified and treatment/support is being established) or 
during acute periods (to assist communication between 
local and specialist services).
Similarly, some patients and carers may prefer to retain 
more control over coordinating their care and preferences 
may change as personal circumstances do. For exam-
ple, as parents return to work after maternity leave their 
capacity to be involved in coordinating tasks/attending 
appointments may decrease. Therefore, they may require 
the support of a coordinator more during this time.
At the moment I’m on maternity leave so I have 
more time to do these things, but when I’m back at 
work, trying to organise everything and keep track 
of everything, time to book appointments and stuff 
is tricky. [carer, undiagnosed]
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Changing the organisation of appointments and clinics
As demonstrated by the experience of one patient, who 
was able to attend several appointments at the same 
location on the same day, the way that clinics are sched-
uled can reduce the time/burden on patients and carers, 
particularly the time/burden associated with travelling 
to and attending uncoordinated appointments. Other 
approaches were suggested. A family-centred approach 
to clinics (where more than one family member, with 
the same condition, could be seen on the same day) 
could improve communication and decision making 
between paediatric and adult services whilst reducing 
the costs to families associated with attending two sets of 
appointments.
Some approaches may not be feasible locally and 
although many participants recognised the value of 
receiving care at a specialist centre and felt it outweighed 
costs of travelling, the advantages of accessing specialist 
care locally or remotely were addressed. For example, the 
provision of services locally (such as via special schools 
or Child Development Centres) have the benefit of saving 
time on travel (and the associated travel costs) and being 
a familiar environment for the family. Many participants 
also realised the benefits of having some consultations 
virtually—particularly with specialists who were based 
far away and where face to face contact was not essential 
for every appointment. Interviewees commented on the 
usefulness of virtual appointment options—especially for 
those who experience fatigue.
Preferences regarding the timing and scheduling of 
appointments may also change depending on the needs 
of individual patients. For example, older children may be 
more able to cope with a full day of appointments, com-
pared to a younger child.
As he gets older I think sometimes it would be nice 
if we could have multiple appointments on the same 
day. That would really help, because you’re not then 
having three appointments… When they’re very 
small it’s difficult and one appointment a day is bet-
ter because attention spans are limited and every-
thing else. [carer, undiagnosed]
In summary, where the care is provided, what range of 
professionals and services are available at appointments, 
and how appointments are scheduled (timing, organisa-
tion) are all likely to influence how appointments impact 
on patients and carers. Interviewees felt that appoint-
ments should be scheduled to meet individual needs—
one approach may not fit all.
Improving communication between stakeholders
One parent described an initiative (‘Team Around the 
Child’ meetings) which brought together all professionals 
involved in their child’s care (including both health and 
non-health professionals, local and specialist profession-
als). They argued that it helped promote proactive care 
and information sharing. Interviewees reported other 
ways that professionals can or could work as a multi-dis-
ciplinary team (MDT) including holding MDT clinics.
The need for a care plan (e.g. Education, Health and 
Care Plan (EHCP)) as a communication and coordination 
tool was evident in participants’ calls for everyone to be 
‘singing off the same hymn sheet’, to agree an approach 
and to provide planned, rather than reactive, care. Simi-
larly, guidelines or a care plan for acute scenarios were 
viewed as useful so that patients receive timely access to 
care, particularly locally.
Interviewees felt that having a point of contact for spe-
cialist advice would help with communication—for the 
family when making a decision about whether or not they 
need to go to hospital and/or for   professionals,   such 
as local emergency staff, who require specialist informa-
tion about the condition.
Interviewees highlighted ways in which they thought 
technology could improve communication and informa-
tion sharing. This might be, for example, a computer sys-
tem that allows relevant information to be accessed by 
all professionals involved in a patient’s care as well as the 
patient/carer.
I would like there to be one central website where I 
could log in… I could see when he’s due to see them 
next, I could message Consultants… and I could 
book appointments… maybe I could see his test 
results and stuff too… to actually access these digi-
tally and online would be fantastic. [carer, undiag-
nosed]
Discussion
The study identified two key consequences of uncoordi-
nated care on the patient and carer experience—delays 
and barriers in accessing care and additional time/bur-
den. A range of impacts on patients and parents/car-
ers were identified and grouped into three overarching 
themes relating to physical health, psychosocial impacts 
and financial impacts. Our findings also suggest ways 
in which service users felt negative impacts might be 
reduced, for example, with the support of a professional 
coordinator, using MDTs, care plans, technology and/or a 
point of contact to improve communication, and organis-
ing appointments to meet the needs of patients and fami-
lies (by providing them locally or virtually where possible, 
offering a range of services in one visit, and scheduling 
them at a convenient time for the family). These findings 
are particularly valuable as they suggest the various ways 
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in which services can be (re)designed to meet the needs 
of rare disease patients.
Our findings demonstrated that different levels of care 
coordination (e.g. the involvement of a care coordina-
tor and how clinics/appointments are delivered) may be 
needed at different stages of the patient’s journey and/or 
to meet individual patient preferences. This highlights the 
need for coordination to take into account when new ser-
vices or support are required (e.g. post diagnosis, transi-
tion to adult services) and when care is needed locally in 
non-specialist settings. There may also be key individual 
differences which affect the extent to which one might 
experience the consequences and impacts described in 
this paper. Some impacts may be magnified for some. For 
example, coordinating care may be more burdensome for 
a single parent without a wider support network. Such 
differences also need to be taken into account when con-
sidering how care should be coordinated.
Our data support previous findings from others on the 
burden of living with a rare and/or undiagnosed condi-
tion [10, 11] including: struggling to access appropriate 
expertise, support and information, financial strain (e.g. 
due to changes in employment) and psychosocial impacts 
(such as disruption to everyday life, living with uncer-
tainty, and stress). However, this study offers a unique 
contribution to the existing knowledge base. It has iden-
tified the specific costs and potential benefits associated 
with how care is coordinated, rather than the more gen-
eral consequences and needs associated with living with 
or caring for someone with a rare condition.
We did not quantify the impacts or costs to patients 
such as the extent of travel costs, but it could be argued 
that the impact of poor coordination on patients and fam-
ilies affected by rare conditions is likely to be greater than 
for those with common conditions because of several 
confounding factors. For example, many of the impacts 
of poor care coordination can be attributed to the time 
and financial commitments of attending appointments, 
such as cost of travel, loss of earnings and disruption to 
employment/education. These are likely to be substan-
tial when one considers that rare disease patients visit 
many different professionals and services in short periods 
of time [4, 12] and specialist care may not be provided 
locally. Previous research shows that patients come up 
against a number of challenges within the healthcare sys-
tem due to the rarity and complexity of their condition 
including: misdiagnoses and delays in diagnosis, a lack 
of information and support, and low availability of treat-
ments [19]. This study suggests that uncoordinated care 
also contributes to the challenges faced by patients with 
rare diseases, particularly around accessing care and the 
burden of managing the condition.
Whilst the paper presents the impacts across three 
overarching themes (physical health, psychosocial and 
financial), it is important to note the interrelations 
between them. This is supported by previous research 
which found that parents faced financial challenges as 
a result of their caring role, which in turn was a major 
source of stress [11] and the findings of a recent study 
which highlighted a number of factors affecting the 
mental health of rare disease patients and their carers 
including trying to access services and support (includ-
ing financial and non-medical support) [20]. Whilst it is 
helpful to categorise different impacts (for example, for 
identifying measures for evaluation and further research), 
the complex inter-dependencies found in reality should 
be recognised.
Findings support recent research which has found that 
patients and carers take on significant tasks in relation 
to care coordination and management [10, 21]. Having 
professional support to coordinate care could reduce 
the negative impact on patients and carers (and others), 
however, this support could take many different forms 
and there is further research and consultation required 
to establish the extent to which responsibility should be 
transferred from patient to professional.
Previous research has shown common challenges and 
needs across rare diseases, which are nevertheless unique 
to those with rare conditions [11, 19, 22]. Therefore, the 
collective experience of those with rare diseases is useful 
and should inform how care is coordinated in services for 
patients with rare conditions, including condition spe-
cific services. It is however also important to recognise 
the diversity of views among individuals and this study 
concludes that care coordination approaches should be 
flexible to meet the needs of different patients and carers 
at different time points.
Fifteen participants took part in this exploratory quali-
tative study. Whilst efforts were made to include a vari-
ety of individuals and experiences, the sample is not 
representative of all those affected by rare diseases. As 
an exploratory and qualitative study, the intention was 
not to recruit a representative sample of the rare disease 
population, but rather to focus on in-depth individual 
accounts which could support the development of data 
collection tools and interpretation of quantitative data in 
the CONCORD study. The data can be used to provide 
an insight into an under-researched area and to inform 
future research. In addition, although positive examples 
of care coordination were shared, it was challenges and 
gaps in care coordination that were more commonly felt 
amongst participants. Therefore, many of the approaches 
outlined in section three of the findings are based upon 
suggestions from participants rather than real life 
scenarios.
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There may be other factors, not included here, which 
have an impact on patient and carers experience of care 
coordination. There may be institutional barriers such 
as: the availability of resources, structural barriers (such 
as the limitations of information systems within NHS 
organisations), and/or cultural obstacles to change. These 
factors should also be considered in the proposal and 
evaluation of new models of coordinated care.
This study identified how care could be coordinated in 
a way which benefits patients with rare conditions, and 
their carers. Further work is required to develop models 
of care coordination, assess their feasibility and evaluate 
them in practice to determine whether the potential ben-
efits we have identified can be realised.
Our findings demonstrate the need for future research 
to collect the views of larger numbers of patients (and 
carers) and consider what might influence differences in 
preferences. This should also be extended to gather the 
views of professionals—those delivering care and sup-
porting patients. This would give an insight into other 
possible impacts associated with how care is coordinated, 
including the impact on the NHS.
The CONCORD study will gather the views of larger 
numbers of people, and of health care professionals and 
patients and carers who are not necessarily members of 
a support group. This exploratory study has informed the 
development of an online survey, incorporating a Dis-
crete Choice Experiment to evaluate preferences for dif-
ferent aspects of coordinated care. The findings will also 
inform the early phase of the development of a taxonomy 
which will provide a comprehensive description of the 
elements of care coordination and how they can be incor-
porated into models of service delivery. The taxonomy 
will form the basis of future cost analyses of different 
models of care.
Conclusion
Our findings provide further evidence of both the chal-
lenges and the importance of coordinating care in the 
context of rare conditions. The findings presented in 
this exploratory qualitative study offer an in-depth view 
of how the patients and carers that we spoke to expe-
rience impacts of care coordination. The study identi-
fies a range of negative consequences associated with 
poorly coordinated care including delays and barriers 
to accessing care, and additional time and burden on 
patients and carers, resulting in physical, psychosocial 
and financial impacts. In addition it proposes a num-
ber of ways that negative impacts might be reduced 
for patients and carers including: having the support 
of a care coordinator, having clinics and appointments 
organised in a way which better meet patient needs, 
and effective communication between professionals 
and services. The findings stress the importance of 
approaches to care coordination which are flexible to 
individual needs and fit for purpose throughout the 
patient journey. Whilst the findings provide an in-
depth view of a small number of participant’s experi-
ences, they may not generalise to all patients and carers 
living with rare conditions. The research should influ-
ence future service developments (and the evaluation 
of such developments).
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